FDA Approves Vaccine to Prevent Shingles in Immunocompromised Adults
July 26th 2021This approval of the non-live, recombinant sub-unit adjuvanted vaccine, Shingrix, is for the prevention of shingles in adults aged 18 years and older with increased risk of immunodeficiency or immunosuppression.
Read More